Immupharma Share Discussion Threads

[nobbygnome] 01/4/2019 08:04

I see it's all going well here as usual.....McCarthy can't even agree with himself!

[newtothisgame3] 01/4/2019 07:48

#IMM #ImmuPharma cancer programme talks continue

[newtothisgame3] 01/4/2019 06:32

#IMMUPHARMA
Last Signal:#BUY
Last Pattern:#BULLISH #ENGULFING
Our system’s recommendation today is to BUY. The BULLISH ENGULFING pattern finally received a confirmation because the prices crossed above the confirmation level which was at 11.1250

[ken chung] 19/3/2019 11:58

Shorters delight.

[pejaten] 15/3/2019 00:29

Basically said nothing new

[a_2_b] 14/3/2019 11:38

Great update today

[master rsi] 13/3/2019 10:16

not much is happening so far on the trading front apart from a better spread 12.30 v 12.70p now on a good position to go for as AT of 2x40K have been taken at the order book.

[ny boy] 12/3/2019 22:25

Tick tick, news coming me things, chatter on the lines.

[kirk 6] 12/3/2019 16:32

Do you ask the same question every single time this has an up tick ?

[master rsi] 12/3/2019 16:24

Look at the volume, a few things are going on,
Oncology Clinical Development Collaboration due this month,
possible divestment of Ureka
and then Q2 test data

[herb clark] 12/3/2019 16:14

Why the rise?

[ken chung] 08/3/2019 09:26

Classic lemming stock.

[brad44] 08/3/2019 07:29

dont put yourself down, just because none of us on here think that much of you, surely Mrs Chung likes you?

[ken chung] 08/3/2019 07:20

Worthless .

[kop202] 04/3/2019 12:10

All that is left is for punters to hit the Johnny Walker Red Label

[pharmaphil] 01/3/2019 07:59

@ buywell3... your latest comment made me laugh, especially after your post on the 24th February at 19.00, kettle and black are a couple of words that come to mind

[a_2_b] 28/2/2019 14:23

Guessing the white label is over now

[buywell3] 28/2/2019 01:15

There is an obvious dearth of people on advfn that do not understand the pre-clinical and clinical trials processes.

A lack of research before buying is apparent also.

Like taking candy from a baby is a phrase that comes to mind.

[ny boy] 27/2/2019 23:31

Lows attracted buyers, more will start buying

[master rsi] 26/2/2019 23:03

Intraday chart bounce
The 5 days chart shows the rise and fall of recent sharp movement, but today managed to bounce from the lows

[njb67] 26/2/2019 22:52

Nature Communications is a peer-reviewed open access scientific journal published by the Nature Publishing Group since 2010. It covers the natural sciences, including physics, chemistry, Earth sciences, and biology.

The founding editor-in-chief was Lesley Anson.[1] The journal has editorial offices in London, New York City, and Shanghai.

Starting October 2014, the journal only accepted submissions from authors willing to pay an article processing charge (currently $5,200 in the United States). The journal typically publishes over 100 articles per week.



So you pay to post your research. A million miles away from serious peer-reviewed journals such as NEJM, JAMA, BMJ etc. Not too far away from advertising on a sandwich board.

Laughable.

(No position)

[ny boy] 26/2/2019 11:15

Crazy gang are back buying the lows!

[ken chung] 26/2/2019 08:20

Master , sadly the data from the Phase 3 trial proves it does not work. That's why it failed Phase 3. To try to convince yourself otherwise is to be deluded and a typical lemming mushroom. Its just a shorters share now while the management drain away the remaining cash to pay for their nice lifestyles.